Total Payments
$628.27
2024 Payments
$53.90
Companies
9
Transactions
22
Medicare Patients
1,898
Medicare Billing
$273,629
Payment Breakdown by Category
Food & Beverage$628.27 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $628.27 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $395.51 | 11 | $0 (2024) |
| Allergan, Inc. | $41.21 | 2 | $0 (2021) |
| Bioventus LLC | $39.71 | 2 | $0 (2023) |
| Vertos Medical, Inc. | $36.62 | 2 | $0 (2022) |
| DePuy Synthes Sales Inc. | $31.10 | 1 | $0 (2022) |
| SPR Therapeutics, Inc | $28.57 | 1 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.12 | 1 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $18.11 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $14.32 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.90 | 2 | ABBVIE INC. ($53.90) |
| 2023 | $345.99 | 10 | ABBVIE INC. ($286.74) |
| 2022 | $187.17 | 8 | ABBVIE INC. ($54.87) |
| 2021 | $41.21 | 2 | Allergan, Inc. ($41.21) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Not Applicable | ||||||
| 11/16/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $28.57 | General |
| Category: Pain management | ||||||
| 03/16/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/06/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/23/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/05/2022 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Orthopedic | ||||||
| 11/07/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/12/2022 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Orthopedic | ||||||
| 10/03/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: PRIMARY CARE | ||||||
| 06/03/2022 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Sports Early Intervention | ||||||
| 05/20/2022 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ORTHOPEDICS | ||||||
| 03/04/2022 | Bioventus LLC | Stimrouter Implantable Kit (Device) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Podiatry | ||||||
| 09/27/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/19/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 431 | 10,320 | $251,528 | $72,354 |
| 2022 | 6 | 488 | 1,206 | $260,140 | $86,449 |
| 2021 | 10 | 545 | 1,110 | $232,841 | $73,787 |
| 2020 | 8 | 434 | 816 | $148,360 | $41,038 |
Total Patients
1,898
Total Services
13,452
Medicare Billing
$273,629
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 358 | $60,533 | $21,401 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 236 | $59,755 | $20,445 | 34.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 69 | 206 | $43,505 | $12,455 | 28.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 43 | 105 | $44,925 | $8,481 | 18.9% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 16 | 9,240 | $23,103 | $5,122 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,177 | $2,726 | 29.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 25 | 45 | $9,000 | $1,719 | 19.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 30 | 47 | $705.00 | $4.70 | 0.7% |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | Office | 2023 | 12 | 60 | $825.00 | $0.75 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 416 | $105,248 | $38,123 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 439 | $74,191 | $27,974 | 37.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 60 | 145 | $30,595 | $9,227 | 30.2% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 45 | 74 | $33,150 | $6,477 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $15,561 | $4,640 | 29.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 39 | 93 | $1,395 | $8.75 | 0.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 444 | $75,036 | $28,391 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 251 | $63,503 | $23,349 | 36.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 81 | 182 | $38,402 | $10,208 | 26.6% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 41 | 78 | $30,550 | $5,946 | 19.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $9,576 | $2,511 | 26.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $5,565 | $1,519 | 27.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 21 | 26 | $3,614 | $853.91 | 23.6% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 19 | 23 | $4,600 | $623.71 | 13.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 18 | $1,350 | $379.85 | 28.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 35 | 43 | $645.00 | $5.36 | 0.8% |
About Muneera Panjwani, APRN
Muneera Panjwani, APRN is a Gerontology healthcare provider based in Middlebury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1053714170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Muneera Panjwani, APRN has received a total of $628.27 in payments from pharmaceutical and medical device companies, with $53.90 received in 2024. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($628.27).
As a Medicare-enrolled provider, Panjwani has provided services to 1,898 Medicare beneficiaries, totaling 13,452 services with total Medicare billing of $273,629. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Middlebury, CT
- Active Since 10/02/2014
- Last Updated 02/13/2020
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1053714170
Products in Payments
- BOTOX (Biological) $412.74
- mild Device Kit (Device) $36.62
- MONOVISC (Device) $31.10
- SPRINT PNS System (Device) $28.57
- UBRELVY (Drug) $23.98
- Stimrouter Implantable Kit (Device) $23.35
- NURTEC ODT (Drug) $23.12
- EUFLEXXA (Device) $18.11
- GELSYN-3 (Device) $16.36
- SEGLENTIS (Drug) $14.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.